These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 28582276)

  • 1. BIOMARKERS OF NEOVASCULAR ACTIVITY IN AGE-RELATED MACULAR DEGENERATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Al-Sheikh M; Iafe NA; Phasukkijwatana N; Sadda SR; Sarraf D
    Retina; 2018 Feb; 38(2):220-230. PubMed ID: 28582276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF TYPE 3 NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Kuehlewein L; Dansingani KK; de Carlo TE; Bonini Filho MA; Iafe NA; Lenis TL; Freund KB; Waheed NK; Duker JS; Sadda SR; Sarraf D
    Retina; 2015 Nov; 35(11):2229-35. PubMed ID: 26502007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: An Optical Coherence Tomographic Angiography Analysis.
    Christenbury JG; Phasukkijwatana N; Gilani F; Freund KB; Sadda S; Sarraf D
    Retina; 2018 Jul; 38(7):1276-1288. PubMed ID: 28723848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration.
    Kuehlewein L; Bansal M; Lenis TL; Iafe NA; Sadda SR; Bonini Filho MA; De Carlo TE; Waheed NK; Duker JS; Sarraf D
    Am J Ophthalmol; 2015 Oct; 160(4):739-48.e2. PubMed ID: 26164826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization.
    Inoue M; Jung JJ; Balaratnasingam C; Dansingani KK; Dhrami-Gavazi E; Suzuki M; de Carlo TE; Shahlaee A; Klufas MA; El Maftouhi A; Duker JS; Ho AC; Maftouhi MQ; Sarraf D; Freund KB;
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT314-23. PubMed ID: 27409488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography angiography patterns of type 1 macular neovascularization in age-related macular degeneration patients.
    Barayev E; Meshi A; Gershoni A; Segal O; Dotan A; Hadayer A; Schaap Fogler M; Ehrlich R; Gal-Or O
    Eur J Ophthalmol; 2023 Jul; 33(4):1697-1705. PubMed ID: 36600606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT.
    Miere A; Querques G; Semoun O; Amoroso F; Zambrowski O; Chapron T; Capuano V; Souied EH
    Retina; 2017 Oct; 37(10):1873-1879. PubMed ID: 28079756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Comparison of Morphologic Characteristics of Type 1 and Type 2 Choroidal Neovascularization in Eyes with Neovascular Age-Related Macular Degeneration using Optical Coherence Tomography Angiography.
    Zhao Z; Yang F; Gong Y; Yu S; Liu H; Wang H; Wang F; Sun X
    Ophthalmologica; 2019; 242(3):178-186. PubMed ID: 31195396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Progression of Type 1 Neovascularization in Age-related Macular Degeneration Using Optical Coherence Tomography Angiography.
    Xu D; Dávila JP; Rahimi M; Rebhun CB; Alibhai AY; Waheed NK; Sarraf D
    Am J Ophthalmol; 2018 Mar; 187():10-20. PubMed ID: 29269100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis and follow-up of type 1 choroidal neovascularisation with optical coherence tomography-angiography after antiangiogenic treatment.
    Torrecillas-Picazo R; Cerdà-Ibáñez M; Almor Palacios I; Hervás Hernandis JM; Ramón-Cosín R; Ruiz Del Rio N; Duch-Samper A
    Arch Soc Esp Oftalmol; 2017 Jun; 92(6):265-272. PubMed ID: 28189273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration.
    Roisman L; Zhang Q; Wang RK; Gregori G; Zhang A; Chen CL; Durbin MK; An L; Stetson PF; Robbins G; Miller A; Zheng F; Rosenfeld PJ
    Ophthalmology; 2016 Jun; 123(6):1309-19. PubMed ID: 26876696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography angiography in age-related macular degeneration: persistence of vascular network in quiescent choroidal neovascularization.
    Wirth MA; Freiberg F; Pfau M; Wons J; Becker MD; Michels S
    Acta Ophthalmol; 2017 Jun; 95(4):428-430. PubMed ID: 27659278
    [No Abstract]   [Full Text] [Related]  

  • 15. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY REVEALS BLOOD FLOW IN CHOROIDAL NEOVASCULAR MEMBRANE IN REMISSION PHASE OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Ichiyama Y; Sawada T; Ito Y; Kakinoki M; Ohji M
    Retina; 2017 Apr; 37(4):724-730. PubMed ID: 28248824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SEMIAUTOMATED QUANTITATIVE APPROACH TO CHARACTERIZE TREATMENT RESPONSE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Real-World Study.
    Roberts PK; Nesper PL; Gill MK; Fawzi AA
    Retina; 2017 Aug; 37(8):1492-1498. PubMed ID: 27997513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 Choroidal Neovascularization Lesion Size: Indocyanine Green Angiography Versus Optical Coherence Tomography Angiography.
    Costanzo E; Miere A; Querques G; Capuano V; Jung C; Souied EH
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT307-13. PubMed ID: 27409487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choroidal Neovascularization Analyzed on Ultrahigh-Speed Swept-Source Optical Coherence Tomography Angiography Compared to Spectral-Domain Optical Coherence Tomography Angiography.
    Novais EA; Adhi M; Moult EM; Louzada RN; Cole ED; Husvogt L; Lee B; Dang S; Regatieri CV; Witkin AJ; Baumal CR; Hornegger J; Jayaraman V; Fujimoto JG; Duker JS; Waheed NK
    Am J Ophthalmol; 2016 Apr; 164():80-8. PubMed ID: 26851725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TYPE 2 NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION IMAGED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    El Ameen A; Cohen SY; Semoun O; Miere A; Srour M; Quaranta-El Maftouhi M; Oubraham H; Blanco-Garavito R; Querques G; Souied EH
    Retina; 2015 Nov; 35(11):2212-8. PubMed ID: 26441269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY; Chung H; Kim HC
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.